BECOME A MEMBER - Get Unlimited CE

  • SIGN IN
  • GET HELP
    •  

    Webinar Details

    Event Type

    Live Online

    Date

    Thursday, December 26, 2024

    Time

    10:30 AM - 11:45 AM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1.25 Contact Hour(s)

    Target Audience

    Pharmacist, Pharmacy Technician

    Cost

    $30.00

    • Overview

      LGBTQIA+ patients face a considerable number of challenges when it comes to obtaining proper HIV care. This session aims to deepen the understanding of HIV, with a particular focus on its impact within the LGBTQIA+ community. The session will explore the critical role of new antiretroviral therapy (ART) in managing HIV, helping reduce morbidity and mortality. Lastly, we’ll highlight how pharmacists can make a significant difference by offering expert guidance on HIV prevention, playing a pivotal role in reducing the spread of the virus.

      This course has been approved by the Florida Board of Pharmacy to fulfill the 1.0 hour of HIV continuing education for Florida pharmacists and pharmacy technicians.




      Handouts

      Slide Document 24237L02_2pp.pdf
      Slide Document 24237L02_6pp.pdf





      Financial Support By

      PharmCon

    • Pharmacist

      Discuss long-acting injectable antiretroviral therapy for patients living with HIV-1
      Identify available pre-exposure prophylaxis (PrEP) for the prevention of HIV-1
      Explain common drug interactions between antiretroviral agents and hormone replacement therapy
      Cite preventative and protective control measures for HIV, identifying the modes of transmission.
      Recognize current Florida law on AIDS and its impact on testing, confidentiality, treatment, and the availability of testing for pregnant women

      Pharmacy Technician

      Discuss long-acting injectable antiretroviral therapy for patients living with HIV-1
      Identify available pre-exposure prophylaxis (PrEP) for the prevention of HIV-1
      Explain common drug interactions between antiretroviral agents and hormone replacement therapy
      Cite preventative and protective control measures for HIV, identifying the modes of transmission.
      Recognize current Florida law on AIDS and its impact on testing, confidentiality, treatment, and the availability of testing for pregnant women

    • Repeat Presentation

      This presentation was last given on 11/27/2024 10:30 AM

      Future Airings

      Date Time
      Saturday, December 28, 2024 11:30 AM View

    • Activity Type

      Knowledge

      CE Broker

      20-1252892

      Universal Activity Number

      Pharmacist 0798-0000-24-237-L02-P

      Pharmacy Technician 0798-0000-24-237-L02-T

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must respond to all randomly-generated participation checks and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


    HARDWARE REQUIREMENTS
    Windows 8.1
    Windows 10
    Apple Mac OS X 10.13 or higher
    iOS 10+
    Android 4.3+


    SOFTWARE REQUIREMENTS
    Google Chrome
    Mozilla Firefox

    Log in locally; do not log in using a VPN, cloud server, remote desktop, etc.


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon. Through this notice, PharmCon. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.

     

    LEARN

    LIVE CE

    HOME STUDY CE

    NEWS

    SPECIALTY CERTIFICATES

    SUPPORT

    ABOUT

    RESOURCES

    CE REPORTING

    CAREER ASSISTANCE

    PATIENT CARE INFO

     

    CE ACTIVITY

    ACCOUNT

    (843) 488 5550 Office

    (843) 488 5554 Fax

    info@freeCE.com Email

    www.freeCE.com Web

    201 N. King of Prussia Rd, Suite 370
    Radnor, PA 19087     Address


     

    ©  PharmCon All Rights Reserved.

    Terms & Conditions

    Privacy Policy

    freeCE is a division of PharmCon